PATIENTS    |   BECOME A PROVIDER    |   PROVIDER PORTAL    |   PROVIDER SEARCH    |   REIMBURSEMENT
PATIENTS    |   BECOME A PROVIDER    |   PROVIDER PORTAL    |   PROVIDER SEARCH    |   REIMBURSEMENT

Effective Medical Devices for Treating Tarsal Tunnel Syndrome

Home > Article > Blog > Effective Medical Devices for Treating Tarsal Tunnel Syndrome
Effective Medical Devices for Treating Tarsal Tunnel Syndrome

Tarsal Tunnel Syndrome (TTS) is a compression neuropathy of the posterior tibial nerve as it passes through the tarsal tunnel, a fibro-osseous canal located posterior to the medial malleolus. This condition is often underdiagnosed and can lead to chronic neuropathic pain, sensory disturbances, and functional impairment if not managed appropriately.

What is Tarsal Tunnel Syndrome? Pathophysiology and Causes

TTS occurs when the tibial nerve or its branches are compressed within the tarsal tunnel, leading to ischemic and inflammatory changes that affect nerve conduction. The compression may result from:

  • Idiopathic factors: Many cases have no clear cause.
  • Post-traumatic fibrosis: Scar tissue formation after ankle injuries or fractures can entrap the nerve.
  • Biomechanical abnormalities: Excessive foot pronation increases strain on the tibial nerve.
  • Space-occupying lesions: Ganglion cysts, lipomas, or varicose veins can exert pressure on the nerve.
  • Systemic inflammatory conditions: Rheumatoid arthritis, diabetes, and hypothyroidism contribute to nerve dysfunction by increasing fluid retention and connective tissue thickening (Physiopedia).

Early intervention with medical devices can help prevent condition progression, reduce dependence on corticosteroid injections and NSAIDs, and, in some cases, eliminate the need for surgical decompression. In this guide, we explore clinically validated medical devices that support nerve decompression, reduce inflammation, and promote functional recovery in TTS management.

What Are the Best Medical Devices for Tarsal Tunnel Syndrome?

Medical devices used for TTS treatment primarily function in three key ways: decompressing the tibial nerve to relieve mechanical pressure, modulating inflammation to promote healing, and supporting biomechanical correction to prevent recurrent compression.

1. Extracorporeal Shock Wave Therapy (ESWT) for Nerve Decompression and Healing

Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive treatment that delivers high-energy acoustic waves to target neuropathic and musculoskeletal conditions. It has been widely used in orthopedic medicine for tendinopathies, fractures, and soft tissue injuries, and more recently, in peripheral nerve entrapments such as TTS.

Mechanism of Action

ESWT influences nerve compression syndromes through the following biological mechanisms:

  • Breakdown of fibrotic adhesions around the tibial nerve, reducing mechanical restriction in the tarsal tunnel.
  • Modulation of inflammation, reducing edema and pro-inflammatory cytokines, which decreases neural irritation.
  • Promotion of nerve regeneration by stimulating vascular endothelial growth factor (VEGF), which improves blood supply to the compressed nerve.
  • Neurostimulation effects, enhancing Schwann cell activity and promoting myelination and functional recovery.

Clinical Findings and Limitations

A clinical study by Mowafy et al. (2020) examined the effects of ESWT on post-burn patients with TTS. The study reported significant improvements in sensory nerve conduction velocity (SNCV) and reduced distal latency, suggesting ESWT can restore nerve function in patients with compression neuropathies (Mowafy et al., 2020). Similarly, Yang et al. (2024) found that ESWT had an excitatory effect on peripheral nerves, improving nerve conduction velocity and reducing neuropathic pain in patients with nerve entrapment syndromes (Yang et al., 2024).

While ESWT demonstrates strong clinical efficacy, its success is dose-dependent, meaning treatment intensity, frequency, and duration influence outcomes. Patients with severe nerve degeneration or chronic fibrosis may require additional interventions, such as orthotic correction or surgical decompression, for full symptom resolution.

SoftWave Therapy: A Broad-Focused ESWT Approach 

SoftWave Therapy is a broad-focused ESWT modality that uses a patented parabolic reflector to deliver wider energy dispersion without causing microtrauma. This advanced technology enables deeper tissue penetration and uniform nerve healing, making it particularly beneficial in neuropathic conditions such as TTS.

Discover SoftWave Therapy for your practice

2. Custom Orthotics: Addressing Biomechanical Causes

Custom orthotics are medical-grade foot inserts designed to correct gait abnormalities that contribute to tibial nerve compression. Unlike generic insoles, custom orthotics are molded to the patient’s foot, ensuring precise biomechanical support. They are often prescribed for foot deformities contributing to tarsal tunnel syndrome, such as:

  • Pes planus (flat feet)
  • Overpronation
  • Postural misalignments affecting tibial nerve tension

Mechanism of Action

  • Redistributes plantar pressures, decreasing mechanical strain on the tibial nerve.
  • Corrects excessive pronation, preventing over-tensioning of the nerve.
  • Supports the medial arch, reducing tibial nerve compression during weight-bearing activities.

Clinical Findings and Limitations

A case study by Hudes (2010) investigated the use of semi-rigid custom orthotics in a TTS patient over a 10-week period. The patient reported significant pain relief and improved foot function, highlighting the role of biomechanical correction in nerve entrapment syndromes (Hudes, 2010).

While custom orthotics are highly effective for biomechanical-induced TTS, they are less useful for cases involving space-occupying lesions, vascular abnormalities, or severe fibrosis. Proper patient selection is essential to ensure clinical success.

3. Bracing, Casts, or Splints: Temporary Symptom Relief

Bracing, casts, and splints are commonly used in the conservative management of tarsal tunnel syndrome (TTS) to provide temporary symptom relief by stabilizing the foot and ankle, reducing nerve compression, and minimizing movement that could aggravate symptoms. While these devices do not address the underlying cause of nerve compression, they can help alleviate pain and inflammation, particularly in the early stages of treatment.

Mechanism of Action

These devices limit excessive foot motion, reducing strain on the tibial nerve and preventing further irritation. They also support biomechanical correction, especially for patients with flat feet, which can increase nerve tension.

  • Braces & Orthotics: CAM walkers and UCBL orthoses improve foot alignment and reduce excessive pronation.
  • Night Splints: Maintain a neutral foot position to relieve nighttime nerve strain.
  • Casts: Provide complete immobilization to reduce inflammation in severe cases.

Clinical Findings and Limitations

Bracing and immobilization often provide short-term pain relief by reducing nerve irritation, but they don’t correct the underlying issue. Prolonged use can lead to muscle weakness and joint stiffness, and poorly fitted devices may worsen symptoms rather than relieve them.

Because of these limitations, braces, splints, and casts should be used alongside physical therapy, nerve gliding exercises, and orthotic adjustments for long-term relief.

4. Pulsed Radiofrequency (PRF) Devices

Pulsed radiofrequency (PRF) therapy is a minimally invasive neuromodulation technique that delivers short bursts of high-frequency radio waves to nervous tissue. Unlike conventional radiofrequency ablation, PRF does not generate sustained thermal damage, making it a safer option for treating neuropathic pain syndromes. PRF has been widely used for nerve pain conditions, including peripheral entrapment syndromes, post-surgical neuropathies, and radiculopathies. Its potential role in tarsal tunnel syndrome (TTS) lies in its ability to modulate pain signaling, reduce neurogenic inflammation, and improve nerve function without compromising motor control.

Mechanism of Action

  • Alters pain transmission by modulating C-fiber and A-delta sensory nerve activity.
  • Inhibits pro-inflammatory cytokines, reducing nerve irritation and hypersensitivity.
  • Induces long-term neuromodulation by increasing endogenous opioid receptor activity.
  • Minimizes nerve demyelination, preserving functional nerve conduction.

Clinical Findings and Limitations

A case series by Chon et al. (2014) examined the effects of ultrasound-guided PRF therapy in two patients with intractable TTS who had failed multiple conservative treatments. Both patients experienced significant pain reduction and decreased analgesic requirements following PRF application to the posterior tibial nerve (Chon et al., 2014).

The study highlighted PRF’s advantage over surgical decompression, as it provided pain relief without motor impairment. However, large-scale randomized controlled trials (RCTs) are lacking, and long-term efficacy data are still limited. 

5. Ultrasound Therapy for Soft Tissue Mobilization

Ultrasound therapy is a non-invasive modality used for diagnostic imaging and therapeutic intervention in musculoskeletal and peripheral nerve conditions. In TTS, ultrasound can both visualize nerve entrapment and serve as a treatment tool for tissue mobilization. High-frequency sound waves penetrate soft tissue, promoting circulation, collagen remodeling, and fibroblast activation.

Mechanism of Action

  • Enhances microcirculation, increasing oxygenation and metabolic activity in the tarsal tunnel.
  • Breaks down fibrotic adhesions, improving nerve gliding and mobility.
  • Reduces inflammation, decreasing peri-neural swelling and mechanical irritation.
  • Stimulates cellular repair, accelerating nerve regeneration and myelin sheath restoration.

Clinical Findings and Limitations

A study by Mowafy et al. (2020) combined pulsed ultrasound therapy with extracorporeal shock wave therapy (ESWT) in TTS patients, demonstrating improved nerve conduction velocity (NCV) and reduced neuropathic pain. The authors suggested that ultrasound-induced mechanical effects enhance nerve recovery when used alongside regenerative therapies (Mowafy et al., 2020).

Further supporting this, Vij et al. (2022) highlighted the use of ultrasound-guided interventions in nerve entrapment syndromes, emphasizing its effectiveness in breaking down perineural fibrosis and enhancing nerve mobility. However, standalone ultrasound therapy is often insufficient for severe cases, and it is most effective when combined with other modalities such as PRF or ESWT.

Why SoftWave Therapy Is an Optimal Solution for TTS and Beyond

SoftWave Therapy offers a distinct advantage over conventional ESWT devices due to its broad-focused energy delivery, non-invasive application, and high patient tolerance. Unlike radial or focused shockwave therapy, SoftWave uses a patented parabolic reflector to distribute shockwaves over a larger treatment area, ensuring deeper penetration without inducing microtrauma.

The SoftWave Gold Li-Series device has FDA clearance and is Health Canada licensed, making it a reliable option for treating neuropathic and musculoskeletal conditions. It is particularly beneficial for tarsal tunnel syndrome, tendinopathies, chronic wounds, and soft tissue injuries. The therapy stimulates angiogenesis, inflammation modulation, and nerve regeneration, promoting sustained functional recovery in peripheral nerve entrapments like TTS.

Become a SoftWave Provider Today

SoftWave Therapy is an ideal addition to any clinical practice, offering a high ROI, rapid treatment sessions, and evidence-backed efficacy. To learn more about integrating SoftWave into your clinic and expanding treatment options for neuropathic conditions, contact us today.

Related Posts